LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Medicinal Shrub Shows Potent Anti-Alzheimer's Disease Potential

By LabMedica International staff writers
Posted on 03 Jul 2017
Extracts from stem, leaves, and root of the African medicinal shrub Carpolobia lutea were found to possess inhibitors of the enzyme acetylcholinesterase (AChE) and antioxidants, which indicate potential for development as a treatment of Alzheimer’s disease (AD) and other disorders characterized by a cholinergic deficit.

Carpolobia lutea, known more commonly as cattle stick, is a small shrub or tree native to Central and West Africa. Herbalists in Nigerian tribes have used the essence of the root as an aphrodisiac and for treatment of genitourinary infections, gingivitis, and waist pains.

Investigators at the University of Nottingham (United Kingdom) scrutinized extracts and fractions of the stem, leaves, and roots of C. lutea for therapeutic promise as an AD treatment via their ability to inhibit AChE. Additionally, extracts and fractions were examined for radical scavenging and reducing (antioxidant) activities, polyphenol and flavonoid content, and C. lutea cytotoxicity.

The study was carried out through sequential solvent extractions of plant stem, leaves, and roots. The extracts were screened for anti-AChE activity across a concentration range of 0.02-200 micrograms per milliliter. Plant DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging activity, reducing power, and total phenolic and flavonoid contents were determined, and cytotoxicity evaluated using human hepatocytes.

Results published in the June 19, 2017, online edition of the journal Pharmaceutical Biology revealed that C. lutea exhibited concentration-dependent anti-AChE activity. The most potent inhibitory activity for the stem was the crude ethanol extract and hexane stem fraction oil; for the leaves, the chloroform leaf fraction; and for roots, the methanol, ethyl acetate, and aqueous root fractions. Dose-dependent free radical scavenging activity and reducing power were observed with increasing stem, leaf, or root concentration. Total phenolic contents were highest in the stem, while total flavonoid content was highest in the leaves. At one microgram per milliliter only the crude ethanol extract oil was significantly cytotoxic to hepatocytes.

Considering the plant's anti-AChE activity and its beneficial antioxidant capacity, the investigators concluded that it had considerable potential for development as a treatment of Alzheimer’s and other diseases characterized by a cholinergic deficiency.

Senior author Dr. Wayne Carter, lecturer and research group leader in the school of medicine at the University of Nottingham, said, "As a population we are living longer and the number of people with dementia is growing at an alarming rate. Our findings suggest that traditional medicines will provide new chemicals able to temper Alzheimer's disease progression."

Related Links:
University of Nottingham

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Hemodynamic System Monitor
OptoMonitor

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more